NEUROPACE INC's ticker is NPCE and the CUSIP is 641288105. A total of 41 filers reported holding NEUROPACE INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,871,765 | +25.1% | 706,245 | -42.3% | 0.00% | – |
Q2 2023 | $5,494,247 | -60.3% | 1,223,663 | -59.0% | 0.00% | -100.0% |
Q1 2023 | $13,854,400 | +541.3% | 2,985,862 | +105.9% | 0.00% | – |
Q4 2022 | $2,160,390 | -60.3% | 1,449,926 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $5,437,000 | -22.6% | 1,449,926 | +2.2% | 0.00% | 0.0% |
Q2 2022 | $7,024,000 | -39.2% | 1,418,951 | +0.8% | 0.00% | 0.0% |
Q1 2022 | $11,554,000 | +7.5% | 1,407,306 | +32.0% | 0.00% | 0.0% |
Q4 2021 | $10,746,000 | -36.4% | 1,066,037 | +0.1% | 0.00% | 0.0% |
Q3 2021 | $16,886,000 | -33.0% | 1,065,385 | +0.5% | 0.00% | -50.0% |
Q2 2021 | $25,219,000 | – | 1,060,059 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KCK LTD. | 5,621,111 | $21,079,000 | 40.88% |
Revelation Capital Management, LLC | 42,972 | $161,000 | 3.78% |
Soleus Capital Management, L.P. | 2,334,003 | $8,753,000 | 1.19% |
Orbimed Advisors | 4,012,281 | $15,046,000 | 0.28% |
Opaleye Management Inc. | 116,324 | $436,000 | 0.18% |
Nantahala Capital Management | 443,502 | $1,663,000 | 0.11% |
Bellevue Group AG | 388,368 | $1,456,000 | 0.02% |
Ergoteles LLC | 31,027 | $116,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 31,648 | $119,000 | 0.00% |
Financial Advocates Investment Management | 10,000 | $38,000 | 0.00% |